Chemotherapy News and Research

Latest Chemotherapy News and Research

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

The superiority of docetaxel based triplet therapy over standard care in patients with resectable oesophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Comprehensive analysis reveals cumulative burden of chronic disease in childhood cancer survivors

The most complete assessment yet of chronic disease in adult survivors of childhood cancer found they have a nearly two-fold greater cumulative burden of chronic health problems than the general public.

8 Sep 2017

Differentiating sepsis and systemic inflammatory response syndrome using biomarkers

Firstly, it is necessary to make a distinction between systemic inflammation and Systemic Inflammatory Response Syndrome (SIRS). SIRS consists of changes in clinical signs including an abnormal body temperature, increased heart rate, increased respiratory rate, an abnormal white cell count (either decreased or elevated), or an increase in band neutrophils.

7 Sep 2017

New microfluidic device offers insights on cancer metastasis

As cancer grows, it evolves. Individual cells become more aggressive and break away to flow through the body and spread to distant areas.

7 Sep 2017

Study identifies genetic alterations with potential to promote aggressiveness of astrocytomas

Among the various types of cancerous brain tumors, 70% are astrocytomas. Fatal in as many as 90% of cases, astrocytomas originate in the largest and most numerous cells in the central nervous system, called astrocytes because of their star shape.

6 Sep 2017

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.

6 Sep 2017

Scientist receives NIH grant to investigate tumor microenvironment from relatively new context

Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.

6 Sep 2017

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for Prostate Cancer) suggests that screening reduced prostate cancer deaths, the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found that regular screening does not reduce the cancer death rates in prostate cancer. Researchers thus looked at the actual picture as to which of these – ERSPC or PLCO are correct.

5 Sep 2017

Another way for anti-vaxxers to skip shots for schoolkids: A doctor’s note

Dr. Tara Zandvliet was inundated with calls and emails from parents last year, after California passed a law nixing personal beliefs as an exemption from school vaccinations. Suddenly, many parents sought exemptions for medical reasons.

5 Sep 2017

Zika virus may one day be effective treatment for deadly brain cancer

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer.

5 Sep 2017

Increased genomic risk can make small tumors aggressive, study says

A study conducted on patients with early stage breast cancer suggested that even small tumors that are thought to be less serious can be aggressive.

4 Sep 2017

Even small tumors can be aggressive in early stage breast cancer patients, study shows

Even small tumors can be aggressive, according to a study in patients with early stage breast cancer that will be presented at the ESMO 2017 Congress in Madrid.

4 Sep 2017

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

European women with ovarian cancer can safely stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 Congress in Madrid.

4 Sep 2017

Existing drug may one day protect premenopausal women from infertility after cancer treatments

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a new study.

1 Sep 2017

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML).

1 Sep 2017

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.

1 Sep 2017

Researchers reveal therapeutic benefits of melatonin for treating blood cancers

Researchers have examined the potential benefits of melatonin, a hormone made by a small gland in the brain, for treating blood cancers such as leukemia and lymphoma.

1 Sep 2017

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.

1 Sep 2017

Motorized molecules driven by light to cut into cancer cells

Researchers have developed a novel technique where molecules would be motorized using light and these would be used to drill holes in the membranes of individual cells such as the cancer cells. This could bring the treatment molecule into the cancer cell directly and cause them to die.

31 Aug 2017

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

The Southeast's first comprehensive cancer treatment program at the University of Alabama at Birmingham takes patient care to the next level by improving the lives of women affected by or at risk for ovarian cancer.

31 Aug 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

Comprehensive analysis reveals cumulative burden of chronic disease in childhood cancer survivors

Differentiating sepsis and systemic inflammatory response syndrome using biomarkers

New microfluidic device offers insights on cancer metastasis

Study identifies genetic alterations with potential to promote aggressiveness of astrocytomas

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Scientist receives NIH grant to investigate tumor microenvironment from relatively new context

Prostate cancer screening reduces cancer deaths finds new analysis

Another way for anti-vaxxers to skip shots for schoolkids: A doctor’s note

Zika virus may one day be effective treatment for deadly brain cancer

Increased genomic risk can make small tumors aggressive, study says

Even small tumors can be aggressive in early stage breast cancer patients, study shows

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

Existing drug may one day protect premenopausal women from infertility after cancer treatments

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Researchers reveal therapeutic benefits of melatonin for treating blood cancers

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

Motorized molecules driven by light to cut into cancer cells

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in